Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Over $500 million per quarter in interest savings alone from 2023 debt reduction and restructuring through Q3. That's major balance improvements plus $1/2 to $2/3 million added to the bottom line each quarter in 2024. People just need to do the math.
Me either (maybe early 2022, don't remember exactly), but there's not much value left on the big boards. Bargain hunters bound to be searching OTC soon. Probably already are.
Out of 000s for good on current valuation. Copper on growth and Jamestown expansion. Silver on speculation and/or realization of revenue/earnings from expansion. Very realistic on a retrace (rebound) factoring dilution since the last RS.
I post facts or opinion based on facts. You post "chit." You try to intimidate people in order to advance whatever scam you are involved in. You cry "scam" because you think everybody is like you. They aren't like you. You are mean spirited and cruel, and you think it's funny. You are the worst of the worst of humanity. You have no good purpose, so you have chosen to be bad and have even adopted a user name to say how bad you are. You are sick.
You have already proven you don't know what DD means. You just spew misinformation and downright lies. Everybody, even your fellow bears, knows you can't be trusted.
All it needs is one more billion share+ investor to do the DD and pull the trigger based on the DD, and the breakout has begun.
RNVA will maximize revenue/earnings from existing services in 2024. Under the CAH model, the revenue/earnings are not just sustainable but as certain as you will see in any company on any exchange. Here's why:
https://icahn.org/wp-content/uploads/2018/10/CAH_Factsheet.pdf
Diggity, please stop using the word "worthless" when you don't understand valuation. Please just stick to ticker watching.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173615513
I just went through a complete list of Nasdaq listed hospitasl. Few have earnings, just losses. RNVA is outperforming all except maybe one comparable PNTG trading at a P/E of 37/1. By comparison, $4 million earnings (py) on 40 billion shares equals a P/E of 1/1. At a 37/1 P/E like PNTG, $4 million in earnings equal a PPS of .0037. Duh.
No RS should be necessary for uplisting to QB. Will probably need an RS to uplist to QX or Nasdaq. An RS to reach the QX ($4 I think) is not a problem because most investors in those exchanges will understand valuation measures, beginning with the P/E ratio which does not change on a RS.
With exceptions like some who post on this board, OTCBB pink invesors seem oblivious to valuation. They just chase unsustainable short term revenue at best but mostly MA rumors, the next shiny object (see HMBL), and the momentum they generate.
RNVA already meets most uplisting requirements except for PPS. I'm not sure when the independent director requirement kicks in, QB or QX, but RNVA already meets that too. RNVA is going to pennies based on historical valuation of stocks on OTC exchanges.
Might do an RS to meet the minimum OTCQX price. A PPS in pennies meets the OTCQB minimum. Won't need to do an RS to meet the OTCQB minimum price, nor should they do an RS in order to meet it.
Why would they dilute, jay? RNVA is profitable, no need for dilution. Might even be able to fund startup cost of the Jamestown reopening with cash flow from existing operations. And even if they issue new shares for Jamestown, that's expansion not dilution. Actually, they may have already raised what they need for Jamestown with that prospectus. It is all about EPS now, not the size of the OS.
I have posted what I know about the supplement filed today. This is what I think it boils down to. The selling shareholder has decided (agreed) to hold a remaining portion of shares in the prospectus until the stock is uplisted with a standing corporate buyback offer at .00014. (Corporate buybacks are not subject to SEC insider trading plan requirements.)
Man, I do know what it's like to take a big loss on a stock, so I feel for you. But the supplement to insider trading plan/prospectus confirms RNVA is profitable and, how many ever shares the selling shareholder still has in the prospectus are no longer required to sell. Why not? Because RNVA doesn't need the proceeds, but the selling shareholder still prohibited from selling higher than .00014 until the stock is uplisted. RNVA not raising capital for salaries or anything else for that matter. Why not? Because it is profitable and confident enough in its profitablility to revise the insider trading plan/prospectus accordingly.
Profitable companies only do RSs to lock in an uplisting, so I will definately "seeya" there to get the last laugh. Now, you can go away until then.
Preferred shares don't convert to more than their original percentage of the market cap. Those that have been converted have been converted at a far lower percentage of the market cap because they were diluted along with common shares. You either don't understand how preferred shares work, or you are just a liar.
You are brushing off an old lie and using it because the news today disproved the lies you have been tellin lately. People, don't let Goon confuse you. Half of the common share equivilency is "antidilutive" and only tell you how much preferred shares were diluted along with common shares. The others are restricted and can't be converted to the full equivilency,
Lmao at you. A very profitable 2024 has been locked in through dynamic revenue increases, cost reductions, and debt paid off and/or restructured in 2023. Earnings cleaned up a heck of a lot crap, and fast because RNVA was artifically dilluted by short selling and being oversold generally in 2022, the year you lost all your money. The EPS is rapidly growing into the share structure as we speak.
Proof. Good work.
Might take a few days or weeks for the market to catch on. Insider buys and corporate buybacks of common shares could come into play now, though I suspect more debt redution is still the priority for the company as it should be. New commercial investors could also come in, but in common shares rather than preferred shares.
Wrong question. It's about the ask not the bid. The street can take out the ask now.
This filing also means RNVA kicked ass in Q4 just as the CEOs guidance indicated. Next comes the good part, the part where we all make a lot of money!
Wow is right! Marvelous amendment to the RNVA insider trading plan. Bottom line, RNVA no longer needs new capital. Some of the existing corporate equity has only shifted from prefered shares to common shares, just like I have been saying.
Turned out the ticker symbol TSNP and a tiny, breakeven retail flooring company was worth a heck of a lot more than .0001.
Varmit, as a value investor I don't claim to know much about timing any particular investment or timing the market as a whole. I hoped we might see more speculative OTC buying last year, but this thing seems poised to breakout anytime now on valuation alone, and then maybe some speculative buying will follow that. That would be the opposite of what has happened in the past, but the OTC market has changed so much that value investments will carry more weight. You have some experience with these 000 breakouts. Am I making sense?
Actually, that dillution happened back when the preferred shares were issued. Is common shareholders holding a larger percentage of corporate equity a good or a bad thing? I say it depends. Somebody thought buying a couple of hundred million shares in a profitable company this morning was a pretty good thing.
$1.54 million 2023 profit through Q3 compared to a $335 million loss during the same period of 2022. New revenue from Myrtle Recovery Center began in Q4. Damned right. Past RSs are just that..., past.
Would you hire them?
You have never made an honest comment on this board, always factually false. You just spend your day trying to intimidate people who like the stock.
Jay, the bulls are all in on this thing. That's the only agenda I see on that end. The bears' motives are unknown. If they have no stake, what's the point for them?
So you consider people who are open and honest to be losers. That pretty much sums up your character.
Breakout time..., finally.
You still don't get it. RS was to $1 per share. Factor ALL dilution since and you get .10 per share round numbers. The company is worth more now than when the RS occured. Reducing debt at a rate of $4 million PY. Reduced interest cost by $1.5 million PY through debt restructuring. More restructuring of debt and "other securities" happening as we speak. RNVA is artificially dilututed due to OTC market conditions (including disproportional short selling). Artificial dilution cleans up fast and easy. Most investors want to see RNVA repilicate the CAH model at Jamestown and elsewhere, in which case cancelling shares would throw a wet blanket on growth.
Debt reduction on a $4 million PY pace plus $1.5 million PY in interest savings from debt restructuring plus more restructuring of debt and "other securities" in the works.(10/25) Ridiculously undervalued.
FYI: Corporate buybacks are not subject to SEC insider trading disclosure requirements. No advance or immediate reporting required. No 90 day minimum cooling off period. A company may disclose only in its quarterly and annual reports, or it may also wait until all buybacks are completed and then release the info.
https://www.davispolk.com/insights/client-update/sec-mandates-new-disclosures-stock-buybacks
Strong buy recommendation on RNVA from God.
News coming anytime on the following:
- Q4 revenues $4.5 to $5.5 million? "Lagan responded that the current operations plus the behavioral health business should give the Company an annualized run rate of $25-30 million by year end. (08/21)
- Corporate equity buyback and/or more debt reduction to add to more than $2 million reduced through Q3? “The debt restructuring improves our balance sheet and will save approximately $1.5 million in interest expense annually. In addition, we are in discussions about other potential modifications to debt and other securities in the hope we can secure additional amendments that further improve our overall financial position.” (10/25)
- Jamestown CAH approval? "He (Lagan) went on to remind Davis that there were still some items to be fixed from previous more difficult days but explained the intention to formulate a plan before year end to duplicate the current (Critical Access Hospital) model in the Jamestown facility in 2024, and stated that if that was successful it would be possible to leave 2024 with annualized revenues of $50-60 million. (08/21)
Best oif all New Years to you! Will be wild.
.0025/.025/.25. That will work for now. Can adjust based on annual report, company guidance, and other events. Penny stock in 2025.